News

The patent covers the methods for synthesizing VAL-083, which is presently being assessed in Phase I/II trial in the US to treat glioblastoma multiforme (GBM). DelMar Pharma president

About 15% of participants in IMAGINE study have completed the full 12-month treatment period, whereas 100% completed a minimum of six month treatment. Patients completing full treatment term

According to the deal, Avanir will be responsible for the regulatory, manufacturing, supply-chain and commercialisation activities of the product, named AVP-825, while both the companies will work on

The Phase I, single-centre study in adults with hyper-responsive airways will determine the probable occurrence of bronchoconstriction after single escalating doses of ALX-0171 in addition to its repeated

Conducted in 50 centres throughout the US, the study will randomise 175 patients with either VTX-2337 or placebo in combination with cetuximab, platinum and 5-FU chemotherapy. The primary

Sales proceeds from the offering will be used by Sarepta for general corporate purposes, such as manufacturing scale up for eteplirsen. Additionally, it also intends to use the

Sources close to the matter have been quoted by Reuters as saying that Toksoz has employed JP Morgan Chase, Istanbul-based Alpacar Associates and US boutique adviser Greenhill to

The touch-screen application, which has been developed using Sencha’s Touch platform, provides a representation of a patient’s teeth digitally, which ultimately enables dentists to streamline their charting, reported

Indicated for use as part of a complete treatment plan, including counseling and psychosocial support, the once-daily, sublingual tablet is an advanced formulation of buprenorphine and naloxone. Expected